The applications of photodynamic therapy (PDT) are usually limited by photosensitizer's side
effect and the singlet oxygen's short half-life. Herein, we demonstrate a dual-targeting (both …

Photodynamic therapy (PDT) has been recognized as a valuable treatment option for
localized cancers. Herein, we demonstrate a cellular and subcellular targeted strategy to …

Although photodynamic therapy (PDT) has become an attractive strategy for cancer
treatment, its clinical application still suffers from some limitations, including insufficient …

Photodynamic therapy (PDT) is an emerging clinical modality for the treatment of a variety of
diseases. Most photosensitizers are hydrophobic and poorly soluble in water. Many new …

Mitochondria-targeted photodynamic therapy (PDT) has emerged as one of the most
efficient antitumor strategies. However, the therapeutic outcome of mitochondria-targeted …

The development of more efficient photosensitizers with minimal damage to surrounding
normal tissues has been a valuable and challenging subject during photodynamic therapy …

Photodynamic therapy (PDT) has been gaining popularity in both scientific research and
clinic applications due to its non-invasiveness and spatiotemporal targeting properties …

The aggregation-caused quenching, premature drug release, and hypoxia-caused
resistance of photodynamic therapy (PDT) are challenges in the design and preparation of …

Photodynamic therapy (PDT), where a photosensitizer (under light irradiation) converts
molecular oxygen to singlet oxygen to elicit programmed cell death, is a promising cancer …

The natural planar and rigid structures of most of the hydrophobic photosensitizers
(PSs)[such as tetraphenyl porphyrin (TPP)] significantly reduce their loading efficiencies in …